5585.T EcoNaviSta (JPX) JPY 2184 intraday Mar 2026: oversold bounce, 23.64% target

The 5585.T stock trades at JPY 2184.00 on JPX intraday, setting a clear oversold bounce setup after a three‑month slide of -9.15% and strong YTD gains of 50.62%. Volume is thin at 3,300 shares versus an average of 41,287, so any rebound may be sharp and short lived. The company’s PE of 58.47 and EPS of 37.35 reflect growth expectations but increase downside risk if sentiment cools. We outline technical triggers, valuation context, Meyka AI grade, and a practical trade plan for an intraday oversold bounce strategy on 5585.T stock.

Technical setup for 5585.T stock

Intraday price action shows JPY 2184.00 with a day low of JPY 2184.00 and day high of JPY 2190.00. Relative volume is 0.08, so moves can be exaggerated. The Keltner channel middle sits at JPY 2184.00 with upper and lower bands at JPY 2196.00 and JPY 2172.00, respectively. The three‑month change is -9.15% while YTD is +50.62%, signalling a recent pullback after strong seasonal strength. For an oversold bounce setup, watch for a sustained print above JPY 2190.00 on higher-than-average volume before adding exposure.

Fundamentals and valuation for 5585.T stock

EcoNaviSta reports EPS 37.35 and a trailing PE 58.47, implying expensive near‑term earnings expectations. Book value per share is JPY 522.61 and cash per share is JPY 427.24, supporting a strong balance sheet. Price to book is 4.18 and price to sales is 15.57, reflecting software and AI premium in the medical information services niche. Gross margin is 71.16% and net margin is 25.94%, showing efficient profitability despite the high multiple.

Liquidity, float and sector context for 5585.T stock

Shares outstanding are 7,244,740, market cap JPY 15,822,512,160.00, and average volume 41,287, which creates low intraday liquidity risk. Healthcare sector average PE is 23.41 versus EcoNaviSta’s 58.47, marking a valuation premium. Low float and narrow trading windows amplify price swings in an oversold bounce strategy, so size positions conservatively and monitor sector flows in Healthcare, which has a 3‑month performance of -0.20%.

Meyka AI rates 5585.T with a score out of 100

Meyka AI rates 5585.T with a score out of 100: 72.15 (Grade B+, Suggestion BUY). This grade factors in S&P 500 comparison, sector and industry performance, financial growth, key metrics, and analyst consensus. Meyka AI, an AI‑powered market analysis platform, highlights strong balance sheet metrics and growth but flags the high PE. Grades are model outputs and not advice; perform your own research.

Price catalysts, earnings and risks for 5585.T stock

Key catalysts include adoption of the Liferhythmavi + Dr. product and new nursing‑care DX contracts that can lift recurring revenue. EcoNaviSta’s reported revenue growth last fiscal was 24.42% and net income growth 22.47%, underlining execution. Main risks are the high PE of 58.47, thin liquidity, and limited free cash flow disclosures. Watch corporate releases on product rollouts and any healthcare procurement news for intraday volatility.

Trade plan for an oversold bounce on 5585.T stock

For intraday traders, consider a small entry above JPY 2190.00 with an initial stop below JPY 2050.00 to cap downside. Target partial profit at JPY 2500.00 and full‑target at JPY 2700.00, aligned with Meyka AI’s model. Keep position size limited given average volume 41,287 and current volume 3,300. Use tight risk management and avoid overnight exposure on this low‑liquidity Healthcare name. See our Meyka stock page and company site for filings and updates.

Final Thoughts

Key takeaways for the 5585.T stock intraday oversold bounce: price sits at JPY 2184.00 with very low current volume, a stretched PE of 58.47, and solid margins that support a rebound trade but not a buy‑and‑hold thesis without further evidence. Meyka AI’s forecast model projects JPY 2700.00, which implies an upside of 23.64% versus the current price JPY 2184.00. That projection assumes renewed demand for EcoNaviSta’s DX solutions and stable sector sentiment. Given the narrow float and thin intraday liquidity, traders should size positions small, use stops, and confirm strength with volume above 41,287. Forecasts are model‑based projections and not guarantees; monitor company updates and Healthcare sector flows. For filings and primary data check the company site and JPX listing for official notices Company website JPX.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.